Business: Nektar Therapeutics is a research-based, development stage biopharmaceutical company whose mission is to discover and develop innovative medicines to address the unmet medical needs of patients. The Company's R&D pipeline of new investigational medicines includes treatments for cancer, auto-immune disease and chronic pain. They leverage Nektar's proprietary and proven chemistry platform in the discovery and design of their new therapeutic candidates. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India.